ONL Therapeutics Treats First EU Patient in GALAXY Phase 2 Trial
Enrollment begins in Switzerland as the company continues to activate clinical sites beyond the U.S. market ONL Therapeutics, Inc., a clinical-stage biopharmaceutical company developing novel...